IP rules exemption for world's poorest "countries falls short"
This article was originally published in Scrip
The World Trade Organization has granted the world's poorest countries a five-year stay of execution for applying WTO TRIPS Agreement intellectual property rules to pharmaceuticals. But the WTO's "half-hearted compromise" on a plea from least-developed countries to exempt them altogether is unsatisfactory because the exemption is still time bound, says Médecins Sans Frontières.
You may also be interested in...
WTO member states including the EU, the US and the UK argue that waiving certain IP rights is unnecessary for enhancing responses to the Covid-19 pandemic.
Insurers argue that better use of real world data and multiple pricing assessments could help lower drug prices in Germany.
To keep investors happy, companies will have to start showing that their high-priced advanced therapies offset costs elsewhere in the health care system.